The application of L-theanine for patients with mental health conditions - a review
DOI:
https://doi.org/10.12775/JEHS.2024.53.010Keywords
L-theanine, anxiety, depression, bipolar disorder, schizophrenia, sleep disorderAbstract
L-theanine is an amino-acid found in green tea (Camellia sinensis), a beverage consumed by people all around the world. Its chemical structure is similar to L-glutamic acid. L-theanine acts as an antagonist of AMPA and kainate receptors as well as partial co-agonist of the NMDA receptors. The application may be associated with several health benefits, such as improvements in cognition, reduction of stress and anxiety-like symptoms. Although the dosage of L-theanine in green tea, which is around 20 mg per tea, is not very likely to have meaningful impact on mental health, supplementation of doses 200-400 mg/day has shown some promising advantages.
Despite some evidence towards beneficial impact of L-theanine on mental health, longer-term and larger cohort clinical studies are required in order to justify its application for patients suffering from such diseases as anxiety, depression, bipolar disorder, schizophrenia and sleep disorders. What is more, it is more possible to act as a therapy augmentation in particular cases, rather than conventional therapy replacement.
References
Li MY, Liu HY, Wu DT, Kenaan A, Geng F, Li HB, Gunaratne A, Li H, Gan RY. L-Theanine: A Unique Functional Amino Acid in Tea (Camellia sinensis L.) With Multiple Health Benefits and Food Applications. Front Nutr. 2022 Apr 4;9:853846. doi: 10.3389/fnut.2022.853846. PMID: 35445053; PMCID: PMC9014247.
Türközü D, Şanlier N. L-theanine, unique amino acid of tea, and its metabolism, health effects, and safety. Crit Rev Food Sci Nutr. 2017 May 24;57(8):1681-1687. doi: 10.1080/10408398.2015.1016141. PMID: 26192072.
Nobre AC, Rao A, Owen GN. L-theanine, a natural constituent in tea, and its effect on mental state. Asia Pac J Clin Nutr. 2008;17 Suppl 1:167-8. PMID: 18296328.
Kimura K, Ozeki M, Juneja LR, Ohira H. L-Theanine reduces psychological and physiological stress responses. Biol Psychol. 2007 Jan;74(1):39-45. doi: 10.1016/j.biopsycho.2006.06.006. Epub 2006 Aug 22. PMID: 16930802.
Stroebel D, Mony L, Paoletti P. Glycine agonism in ionotropic glutamate receptors. Neuropharmacology. 2021 Aug 1;193:108631. doi: 10.1016/j.neuropharm.2021.108631. Epub 2021 May 28. PMID: 34058193.
Brosnan JT, Brosnan ME. Glutamate: a truly functional amino acid. Amino Acids. 2013 Sep;45(3):413-8. doi: 10.1007/s00726-012-1280-4. Epub 2012 Apr 18. PMID: 22526238.
Chapman AG. Glutamate and epilepsy. J Nutr. 2000 Apr;130(4S Suppl):1043S-5S. doi: 10.1093/jn/130.4.1043S. PMID: 10736378.
Hidese S, Ogawa S, Ota M, et al. Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial. Nutrients. 2019 Oct;11(10):E2362. DOI: 10.3390/nu11102362. PMID: 31623400; PMCID: PMC6836118.
Anas Sohail A, Ortiz F, Varghese T, Fabara SP, Batth AS, Sandesara DP, Sabir A, Khurana M, Datta S, Patel UK. The Cognitive-Enhancing Outcomes of Caffeine and L-theanine: A Systematic Review. Cureus. 2021 Dec 30;13(12):e20828. doi: 10.7759/cureus.20828. PMID: 35111479; PMCID: PMC8794723.
Williams JL, Everett JM, D'Cunha NM, Sergi D, Georgousopoulou EN, Keegan RJ, McKune AJ, Mellor DD, Anstice N, Naumovski N. The Effects of Green Tea Amino Acid L-Theanine Consumption on the Ability to Manage Stress and Anxiety Levels: a Systematic Review. Plant Foods Hum Nutr. 2020 Mar;75(1):12-23. doi: 10.1007/s11130-019-00771-5. PMID: 31758301.
Haskell CF, Kennedy DO, Milne AL, Wesnes KA, Scholey AB. The effects of L-theanine, caffeine and their combination on cognition and mood. Biol Psychol. 2008 Feb;77(2):113-22. doi: 10.1016/j.biopsycho.2007.09.008. Epub 2007 Sep 26. PMID: 18006208.
Duman RS, Sanacora G, Krystal JH. Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments. Neuron. 2019 Apr 3;102(1):75-90. doi: 10.1016/j.neuron.2019.03.013. PMID: 30946828; PMCID: PMC6450409.
Uno Y, Coyle JT. Glutamate hypothesis in schizophrenia. Psychiatry Clin Neurosci. 2019 May;73(5):204-215. doi: 10.1111/pcn.12823. Epub 2019 Mar 6. PMID: 30666759.
Lopes Sakamoto F, Metzker Pereira Ribeiro R, Amador Bueno A, Oliveira Santos H. Psychotropic effects of L-theanine and its clinical properties: From the management of anxiety and stress to a potential use in schizophrenia. Pharmacol Res. 2019 Sep;147:104395. doi: 10.1016/j.phrs.2019.104395. Epub 2019 Aug 11. PMID: 31412272.
Lopes Sakamoto F, Metzker Pereira Ribeiro R, Amador Bueno A, Oliveira Santos H. Psychotropic effects of L-theanine and its clinical properties: From the management of anxiety and stress to a potential use in schizophrenia. Pharmacol Res. 2019 Sep;147:104395. doi: 10.1016/j.phrs.2019.104395. Epub 2019 Aug 11. PMID: 31412272.
White DJ, de Klerk S, Woods W, et al. Anti-Stress, Behavioural and Magnetoencephalography Effects of an L-Theanine-Based Nutrient Drink: A Randomised, Double-Blind, Placebo-Controlled, Crossover Trial. Nutrients. 2016 Jan;8(1):E53. DOI: 10.3390/nu8010053. PMID: 26797633; PMCID: PMC4728665.
Sarris J, Byrne GJ, Cribb L, Oliver G, Murphy J, Macdonald P, Nazareth S, Karamacoska D, Galea S, Short A, Ee C, Birling Y, Menon R, Ng CH. L-theanine in the adjunctive treatment of generalized anxiety disorder: A double-blind, randomised, placebo-controlled trial. J Psychiatr Res. 2019 Mar;110:31-37. doi: 10.1016/j.jpsychires.2018.12.014. Epub 2018 Dec 8. PMID: 30580081.
Keller J, Gomez R, Williams G, Lembke A, Lazzeroni L, Murphy GM Jr, Schatzberg AF. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Mol Psychiatry. 2017 Apr;22(4):527-536. doi: 10.1038/mp.2016.120. Epub 2016 Aug 16. PMID: 27528460; PMCID: PMC5313380.
Rothenberg DO, Zhang L. Mechanisms Underlying the Anti-Depressive Effects of Regular Tea Consumption. Nutrients. 2019 Jun;11(6):E1361. DOI: 10.3390/nu11061361. PMID: 31212946; PMCID: PMC6627400.
Shen M.J., Yang Y., Wu Y., Zhang B.B., Wu H.S., Wang L., Tang H., Chen J.D. L-theanine ameliorate depressive-like behavior in a chronic unpredictable mild stress rat model via modulating the monoamine levels in limbic-cortical-striatal-pallidal-thalamic-circuit related brain regions. Phytother. Res. 2019;33:412–421. 10.1002/ptr.6237
Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry. 2023 Aug;28(8):3243-3256. doi: 10.1038/s41380-022-01661-0. Epub 2022 Jul 20. PMID: 35854107; PMCID: PMC10618090.
Blacker CJ, Lewis CP, Frye MA, Veldic M. Metabotropic glutamate receptors as emerging research targets in bipolar disorder. Psychiatry Res. 2017 Nov;257:327-337. doi: 10.1016/j.psychres.2017.07.059. Epub 2017 Jul 31. PMID: 28800512.
Dean RL, Marquardt T, Hurducas C, Spyridi S, Barnes A, Smith R, Cowen PJ, McShane R, Hawton K, Malhi GS, Geddes J, Cipriani A. Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder. Cochrane Database Syst Rev. 2021 Oct 8;10(10):CD011611. doi: 10.1002/14651858.CD011611.pub3. PMID: 34623633; PMCID: PMC8499740.
Dixon JF, Hokin LE. Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex. Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8363-8. doi: 10.1073/pnas.95.14.8363. PMID: 9653192; PMCID: PMC20981.
Sills GJ, Rogawski MA. Mechanisms of action of currently used antiseizure drugs. Neuropharmacology. 2020 May 15;168:107966. doi: 10.1016/j.neuropharm.2020.107966. Epub 2020 Jan 14. PMID: 32120063.
Dogra S, Conn PJ. Metabotropic Glutamate Receptors As Emerging Targets for the Treatment of Schizophrenia. Mol Pharmacol. 2022 May;101(5):275-285. doi: 10.1124/molpharm.121.000460. Epub 2022 Mar 3. PMID: 35246479; PMCID: PMC9092465.
Shamabadi A, Fattollahzadeh-Noor S, Fallahpour B, A Basti F, Khodaei Ardakani MR, Akhondzadeh S. L-Theanine adjunct to risperidone in the treatment of chronic schizophrenia inpatients: a randomized, double-blind, placebo-controlled clinical trial. Psychopharmacology (Berl). 2023 Dec;240(12):2631-2640. doi: 10.1007/s00213-023-06458-9. Epub 2023 Sep 12. PMID: 37697164.
Clark I, Landolt HP. Coffee, caffeine, and sleep: A systematic review of epidemiological studies and randomized controlled trials. Sleep Med Rev. 2017 Feb;31:70-78. doi: 10.1016/j.smrv.2016.01.006. Epub 2016 Jan 30. PMID: 26899133.
Jang HS, Jung JY, Jang IS, Jang KH, Kim SH, Ha JH, Suk K, Lee MG. L-theanine partially counteracts caffeine-induced sleep disturbances in rats. Pharmacol Biochem Behav. 2012 Apr;101(2):217-21. doi: 10.1016/j.pbb.2012.01.011. Epub 2012 Jan 21. PMID: 22285321.
Dasdelen MF, Er S, Kaplan B, Celik S, Beker MC, Orhan C, Tuzcu M, Sahin N, Mamedova H, Sylla S, Komorowski J, Ojalvo SP, Sahin K, Kilic E. A Novel Theanine Complex, Mg-L-Theanine Improves Sleep Quality via Regulating Brain Electrochemical Activity. Front Nutr. 2022 Apr 5;9:874254. doi: 10.3389/fnut.2022.874254. PMID: 35449538; PMCID: PMC9017334.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Michał Łata, Beata Getka, Justyna Kwiecień, Kinga Przyborowska, Katarzyna Wiejak, Mateusz Rukat
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 602
Number of citations: 0